Geneos Wealth Management’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-36
Closed -$3.72K – 2765
2025
Q2
$3.72K Sell
36
-118
-77% -$11.1K ﹤0.01% 2654
2025
Q1
$15.2K Buy
154
+142
+1,183% +$18.9K ﹤0.01% 2071
2024
Q4
$1.8K Hold
12
– – ﹤0.01% 2636
2024
Q3
$1.56K Buy
+12
New +$1.49K ﹤0.01% 2354
2018
Q1
– Sell
-1,783
Closed -$45K – 2196
2017
Q4
$45K Buy
1,783
+978
+121% +$29.1K ﹤0.01% 1043
2017
Q3
$26K Sell
805
-535
-40% -$20.3K ﹤0.01% 1222
2017
Q2
$55K Buy
+1,340
New +$57.7K 0.01% 883
2017
Q1
– Sell
-3,635
Closed -$124K – 2095
2016
Q4
$124K Hold
3,635
– – 0.02% 559
2016
Q3
$137K Hold
3,635
– – 0.02% 532
2016
Q2
$106K Hold
3,635
– – 0.02% 575
2016
Q1
$62K Buy
+3,635
New +$63K 0.01% 733

Other funds holding GKOS

Geneos Wealth Management's GKOS Position: Q3 2025 in Review

Geneos Wealth Management sold out of Glaukos (GKOS) in Q3 2025, closing a stake of 36 shares — an estimated $3.72K sold.

Geneos Wealth Management first reported a position in GKOS in Q1 2016 and held it in 11 quarters. The position peaked at $137K in Q3 2016. 315 funds tracked by Wall St. Rank hold GKOS as of Q3 2025.

  • Geneos Wealth Management reported no remaining Glaukos position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 36 Glaukos shares in Q3 2025, an estimated $3.72K.
  • Geneos Wealth Management first reported a position in Glaukos in Q1 2016 and held it in 11 quarters.
  • Geneos Wealth Management's Glaukos position peaked at $137K in Q3 2016.
  • 315 funds tracked by Wall St. Rank held Glaukos as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.